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Characterization of a Family with Rare Deletions in
CNTNAP5 andDOCK4 Suggests Novel Risk Loci for
Autism and Dyslexia
Alistair T. Pagnamenta, Elena Bacchelli, Maretha V. de Jonge, Ghazala Mirza, Thomas S. Scerri,
Fiorella Minopoli, Andreas Chiocchetti, Kerstin U. Ludwig, Per Hoffmann, Silvia Paracchini,
Ernesto Lowy, Denise H. Harold, Jade A. Chapman, Sabine M. Klauck, Fritz Poustka, Renske H. Houben,
Wouter G. Staal, Roel A. Ophoff, Michael C. O’Donovan, Julie Williams, Markus M. Nöthen,
Gerd Schulte-Körne, Panos Deloukas, Jiannis Ragoussis, Anthony J. Bailey, Elena Maestrini,
Anthony P. Monaco, and the International Molecular Genetic Study Of Autism Consortium
Background: Autism spectrum disorders (ASDs) are characterized by social, communication, and behavioral deficits and complex genetic
etiology. A recent study of 517 ASD families implicatedDOCK4 by single nucleotide polymorphism (SNP) association and amicrodeletion in
n affected sibling pair.
ethods: The DOCK4microdeletion on 7q31.1 was further characterized in this family using QuantiSNP analysis of 1M SNP array data and
everse transcription polymerase chain reaction. Extended family members were tested by polymerase chain reaction amplification of
unction fragments. DOCK4 dosage was measured in additional samples using SNP arrays. Since QuantiSNP analysis identified a novel
NTNAP5microdeletion in the same affected sibling pair, this genewas sequenced in 143 additional ASD families. Further polymerase chain
eaction-restriction fragment length polymorphism analysis included 380 ASD cases and suitable control subjects.
esults: Thematernally inheritedmicrodeletionencompassed chr7:110,663,978-111,257,682and led to aDOCK4-IMMP2L fusion transcript.
twas also detected in five extended familymemberswith noASD.However, six of nine individualswith thismicrodeletionhadpoor reading
bility, which promptedus to screen 606 other dyslexia cases. This led to the identification of a secondDOCK4microdeletion co-segregating
ith dyslexia. Assessment of genomic background in the original ASD family detected a paternal 2q14.3microdeletion disruptingCNTNAP5
hat was also transmitted to both affected siblings. Analysis of other ASD cohorts revealed four additional rare missense changes in
NTNAP5. No exonic deletions of DOCK4 or CNTNAP5were seen in 2091 control subjects.
Conclusions: This study highlights two new risk factors for ASD and dyslexia and demonstrates the importance of performing a high-
resolution assessment of genomic background, even after detection of a rare and likely damagingmicrodeletion using a targeted approach.w
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Autism spectrum disorders (ASDs) are a subset of complexneurodevelopmental disorders characterized by deficitsin three core domains: 1) reduced reciprocal social inter-
ction, 2) impaired ability to communicate, and 3) a narrow
ange of interests and repetitive behaviors. Autism spectrum
isorders are clinically heterogeneous and often show comor-
idity with other conditions such as epilepsy and learning
isability (1,2).
Although autism has consistently been shown to demonstrate
igh levels of heritability, it has only recently become clear that
any of the genes recently implicated in autism are involved
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xample, a pathway-based analysis using data from the first
ublished ASD genome-wide single nucleotide polymorphism
SNP) association study implicated the cadherin gene family. Stron-
er enrichment was seen when these 25 cadherins were combined
ith three neurexins and five neurexin-related CNTNAP genes (3).
utations in neuroligin proteins, which interact with neurexins
cross the synaptic cleft, were associated with autism before
eurexins were implicated (4). Other studies have shown that
enomic copy number variations (CNVs) also play a significant
ole in autism susceptibility (5,6). Hemizygous disruption of the
eurexin 1 gene (NRXN1) was first seen in sisters with ASD (7).
n addition, rare structural variants involving CNTNAP2 have
lso recently been associated with autism susceptibility (8,9),
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A.T. Pagnamenta et al. BIOL PSYCHIATRY 2010;68:320–328 321further implicating this gene family. Drosophila orthologues of
CNTNAP2 and NRXN1 can both reorganize synaptic morphol-
ogy and regulate another synaptic protein bruchpilot (10). It is
hus proposed that a shared synaptic mechanism underlies the
imilar clinical outcomes for patients with NRXN1 or CNTNAP2
mutations.
An emerging trend from recent literature is that many mi-
crodeletion syndromes exhibit considerable phenotypic variabil-
ity. For instance, variable dosage of CNTNAP2 has also been
ocumented in epilepsy and schizophrenia (11), while deletion
f 15q13.3 has been implicated in autism (12), generalized
earning disability (13), epilepsy (14), and schizophrenia (15).
ne possible hypothesis is that additional CNVs elsewhere in the
enome may act as genetic modifiers. In support of this hypoth-
sis, recent studies on schizophrenia have detected more than
ne rare CNV  100 kb within the same affected individual (16).
The autism susceptibility locus 1 (AUTS1), situated on chro-
osome 7q, has been identified in at least four genome-wide
inkage scans (17–20) and two meta-analyses (21,22). A recent
UTS1 fine-mapping study, using both family-based and case-
ontrol association analyses, detected SNPs within DOCK4 (ded-
cator of cytokinesis 4) and IMMP2L (IMP2 inner mitochondrial
embrane protease-like) that may be indexing autism suscepti-
ility factors. A rare genomic deletion disrupting both DOCK4
nd IMMP2L was also detected and shown to be transmitted to
both members of an affected sibling pair (ASP), further implicat-
ing this gene region (23). DOCK4 is a plausible ASD candidate
gene, as recent RNA interference studies using rat hippocampal
neurons have shown that this gene may influence dendritic
branching and growth (24). Genes at this locus have previously
been linked to Tourette syndrome, through association (25) or
cytogenetic aberration (26). Disruption of a related gene,
DOCK3, has also been linked to attention-deficit/hyperactivity
disorder (27). To understand its potential effect, we first charac-
terized the IMMP2L-DOCK4 deletion and resulting fusion tran-
script at base-pair resolution, using a variety of methods. Due to
reports of additional neurological and psychiatric disorders in the
extended family, relatives for whom DNA was available were
also screened for this deletion. The finding that three relatives
with poor reading ability had also inherited the same deletion led
us to further assess an additional dyslexia cohort for genomic
variants in this gene region.
We also assessed the genomic background in the autism
family with the IMMP2L-DOCK4 deletion and detected a second
rare microdeletion disrupting CNTNAP5 in the ASP. As this gene
is related to CNTNAP2, it was sequenced in additional ASD
amilies from the International Molecular Genetic Study of Au-
ism Consortium (IMGSAC) cohort to search for other rare
ariants that might be of etiological relevance to autism.
Methods andMaterials
Clinical Details
The Dutch multiplex autism family 15-0084 volunteered to
participate in the IMGSAC research study, as approved by the
medical ethical commission of the University Medical Center
Utrecht. Extended family members were also asked to participate
and donate saliva samples. Informed consent was obtained from
all participants. Case reports for the proband (15-0084-003), his
affected brother (15-0084-004), and other family members are
given in Supplement 1. Tlinical Assessment
Social communication ability was assessed in all participating
amily members using the Social Responsiveness Scale (SRS)
28). Depending on the age of the participant, either the chil-
ren’s version or the adult informant version was used. The t
cores are reported for the SRS children’s version. For adults, t
cores are unavailable, so the total scores are compared with the
ean total scores in the Dutch population (Ilse L. Noens, Ph.D.,
ritten communication to MVdJ, November 2009). The partici-
ants with a formal diagnosis of autism scored within the severe
ange of the SRS. The total SRS scores of the unaffected family
embers are all between the mean and 1 SD. Reading and
pelling ability were assessed by means of a short battery of
utch word reading, nonword reading, text reading, and spelling
ests. An overall evaluation of communication ability and reading
apacity is presented in Table S1 in Supplement 1.
NA Extraction
DNA was extracted from the saliva samples of the extended
amily using the Oragene DNA Extraction Kit (DNA Genotek,
ntario, Canada), following the manufacturer’s protocol. DNA
rom family 15-0084 had been extracted, as described previ-
usly (18).
MSNP Array and CNV Analysis
A total of 750 ng of genomic DNA was run on the single-
ample Infinium 1M SNP BeadArray (Illumina, San Diego, Cali-
ornia) according to manufacturer’s instructions, with default SNP
lustering. Log R ratios and B allele frequencies were used to call
NVs using the QuantiSNP algorithm (29), with L  2M, expec-
ation-maximization iterations  50, MaxCopy  4, and correct-
ng for local GC content. High confidence calls with log Bayes
actor  10 were used, whereby we expected approximately
ne false CNV call per sample.
ong-Range Polymerase Chain Reaction, Quantitative
ultiplex PCR of Short Fluorescent Fragments, and CNV
alidation
Long-range polymerase chain reaction (PCR) was carried out
ith Bio-X-ACT long DNA polymerase (Bioline, London, United
ingdom) using the manufacturer’s suggested protocol. Primers
TTCACCTTTTGGGGTGCTA and TGGAGCCTGGGAATTAAAAA
ere used to amplify across the IMMP2L-DOCK4 deletion. Nested
NTNAP5 primer sequences are available on request.
Quantitative Multiplex PCR of Short Fluorescent Fragments
QMPSF) was performed as previously described (30), using
NA from 197 multiplex IMGSAC families (320 affected individ-
als) and 461 Caucasian United Kingdom control subjects avail-
ble from the European Collection of Cell Cultures. The QMPSF
rimers (sequences available on request) were designed in
OCK4 exons 1, 8, 15, 25, 31, and 52 to complement our
revious QMPSF analysis, which included IMMP2L exons and
he last exon of DOCK4 (23). Exon 7 of the RNF20 gene was
o-amplified as a control exon.
To ensure that all reported CNV results were verified by at
east two methods, DNA samples from extended family members
ere also tested using quantitative PCR and/or 44 k array-based
omparative genomic hybridization (Agilent, Santa Clara, Califor-
ia).
eal-Time-PCR
Total RNA was extracted from blood samples stored in
NAlater solution using RiboPure Blood Kit (Ambion, Austin,
exas), according to the manufacturer’s instructions. Comple-
www.sobp.org/journal
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322 BIOL PSYCHIATRY 2010;68:320–328 A.T. Pagnamenta et al.mentary DNA (cDNA) was synthesized from 500 ng of total RNA
using the Superscript III First Strand Synthesis SuperMix for
quantitative real-time PCR (qRT-PCR) and random hexamers
(Invitrogen, Eugene, Oregon). Semi-quantitative PCR was per-
formed on 1/20th of the cDNA template prepared as described
above, with two primer pairs specific for DOCK4 (available on
request) and the third designed to amplify the fusion transcript
(IMMP2L-x4fus-F: ATCTCCTTCAAGAGCAATCACT; DOCK4-
x26fus-R: TCTCCTGTCCCTATTACGACAAA), using standard PCR
conditions. The PCR was repeated using an increasing number of
cycles (from 25 to 40). The PCR products were run on 2% agarose
gels in the presence of GelRed (Biotium, Hayward, California).
DOCK4 expression was also evaluated by qRT-PCR using SYBR-
green (Applied Biosystems, Foster City, California) with two
DOCK4 specific primer pairs and the housekeeping gene GUSB
as a control gene. Amplification of serial cDNA dilutions was
performed to calculate PCR efficiencies. For each sample, expres-
sion was measured in triplicate, with mean values used for calcu-
lations. Quantification was calculated using the comparative CT
method (31).
NeuroDys Cohort and Additional Control CNV Data
DNA from 232 probands from the NeuroDys dyslexia cohort
(http://www.neurodys.com), 643 unrelated Dutch control sub-
jects (32), and 1448 control subjects from the British 1958 Birth
Cohort (http://www.b58cgene.sgul.ac.uk) were run on the In-
finium 550 K SNP BeadArray (Illumina), according to manufac-
turer’s instructions. Another 374 cases from the NeuroDys cohort
were run on the Infinium 300K SNP BeadArray (Illumina). Copy
number variation calling was carried out, as described above.
Samples were collected following informed consent. The study
was approved by the relevant ethics committees.
CNTNAP5 Sequencing and Bioinformatic Analysis
Polymerase chain reaction products containing all 24 CNT-
NAP5 exons and intron-exon boundaries were purified using
Exonuclease I (NEB, Ipswich, Massachusetts) and shrimp alka-
line phosphatase (USB, Cleveland, Ohio). Sanger sequencing
was carried out using BigDye v3.1 (Applied Biosystems). Primers
for exons 14, 18, and 22 are listed below; other primer sequences
are available on request. Sample selection strategy is presented
in Supplement 1. Sequence was analyzed with reference to
CNTNAP5 messenger RNA, NM_130773. Bioinformatic analysis
of novel nonsynonymous variants was carried out using Poly-
Phen (http://genetics.bwh.harvard.edu/pph/) (33). This tool pre-
icts the likely impact of amino acid substitutions on protein
unction, using known structure and comparative considerations.
redictions should be interpreted with caution as many known
Table 1. QuantiSNP Data for the IMMP2L-DOCK4 and CNTNAP5 Gene Loci
Sample ID Chr Start (bp) End (bp) Length (bp) S
15-0084-002 7 110,654,771 111,256,808 602,037 rs214
15-0084-003 7 110,666,487 111,256,808 590,321 rs377
15-0084-004 7 110,254,457 111,266,360 1,011,903 rs102
15-0084-005 7 110,247,163 111,266,360 1,019,197 rs156
15-0084-001 2 124,836,663 125,063,827 227,164 rs116
15-0084-003 2 124,836,663 125,063,827 227,164 rs116
15-0084-004 2 124,829,445 125,111,265 281,820 rs757Physical positions shown are according to National Center for Biotechnology
bp, base pair; Chr, chromosome; SNP, single nucleotide polymorphism.
www.sobp.org/journalathogenic mutations come up as benign, suggesting a high
roportion of false-negatives with this method.
CR-Restriction Fragment Length Polymorphism Screening of
dditional Cases and Control Subjects
Exon 14 of CNTNAP5 was amplified using primers TCCAA-
ATATTTTCAGCTCAGTTTC and GGGGGAGCTCCAGTTTG-
AT and standard PCR conditions. The wild-type 362 base pair
bp) PCR amplicon is cut into 141 bp, 24 bp, and 197 bp
ragments by the enzyme MnlI (NEB). One of the CCTC recog-
ition sites is disrupted by the c.2141C G mutation, resulting in
ragments of 141 bp and 221 bp.
Exon 18 was amplified using primers AGACCTTCATGACAA-
AGAGAACT and AAACAGCGGGAGAGTAGATGA. The en-
yme HpyCH4IV (NEB) cuts the wild-type 469 bp amplicon into
19 bp and 350 bp fragments. However, the c.2756C  T
utation disrupts this ACGT recognition site.
Exon 22 was amplified with primers GGAGGTGGGGAAAG-
AGATA and AAAAACTGAGTCACATTAGCCAAC. The c.3502GA
utation creates a BccI (NEB) restriction site (CCATC) in the
iddle of the 490 bp amplicon resulting in 242 bp and 248 bp
ragments, while the c.3584C  T polymorphism creates an
lternative restriction site, resulting in fragments of 179 bp and
11 bp.
All digestion products were visualized on 1.8% agarose gels,
tained with SYBR safe (Invitrogen). Caucasian control samples
ncluded Human Random Control panels available from the
uropean Collection of Cell Cultures, additional German control
NAs, and also DNA from parents of anorexia patients. In
ddition, 380 unrelated German ASD patients (34) were screened
or the c.2756C  T and c.3502G  A variants.
esults
In a recent CNV scan of the AUTS1 locus, we detected a 600
ilobase (kb) deletion involving IMMP2L and DOCK4 in an
utistic ASP. Quantitative PCR had been used to show that the
istal breakpoint lay between exons 14 and 31 of DOCK4 (23).
o further resolve the deletion at both extremities, DNA samples
rom the family were run on 1M SNP arrays. Over 1M SNPs were
alled for all five family members, with low rates of Mendelian
rror (Table S2 in Supplement 1). Using QuantiSNP, the IMMP2L-
OCK4 deletion was the most confidently detected CNV, with a
og Bayes Factor of 777 in proband 15-0084-003 (Table 1 and
able S3 in Supplement 1). These array data were consistent with
ur previous studies that showed that the deletion had been
ransmitted from the reading-impaired mother (15-0084-002) to
ll three children (two boys with autism and their reading-
mpaired sister). However, as the QuantiSNP CNV calls were
End
Number
SNPs
Copy
Number
Log Bayes
Factor Gene(s)
rs6966622 179 1 543.06 DOCK4, IMMP2L
rs6966622 175 1 777.48 DOCK4, IMMP2L
3 rs7783121 310 1 169.92 DOCK4, IMMP2L
rs7783121 311 1 208.85 DOCK4, IMMP2L
2 rs4848944 84 1 117.45 CNTNAP5
2 rs4848944 84 1 313.38 CNTNAP5
rs11900792 94 1 60.77 CNTNAP5tart
475
15
7957
9122
8889
8889
8650Information Build 36.
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A.T. Pagnamenta et al. BIOL PSYCHIATRY 2010;68:320–328 323inconsistent in terms of deletion size, visual inspection of the log
R ratio and B allele frequencies within BeadStudio software
(Illumina) allowed us to determine that the proximal deletion
breakpoint lay between rs37713 and rs37715, while the distal
breakpoint was situated between rs6966622 and rs10238664. This
resolution was sufficient to allow the design of suitable long-
range PCR primers. Amplification across the deletion breakpoint
followed by Sanger sequencing allowed precise characterization
of the 594-kb deletion (Figure 1A). The ACTCYAGCC motif
observed at either end of the chr7:110,663,978-111,257,682 de-
letion (National Center for Biotechnology Information build 36
coordinates) suggested that some sequence similarity-driven
process may have originally led to this deletion.
While IMMP2L shows variable dosage at a similar rate in
autism cases and in control subjects (23), there were no exonic
deletions of DOCK4 listed in the Database of Genomic Variants
(DGV) (March 2009 release, http://projects.tcag.ca/variation/)
(35). We assessed the frequency of DOCK4 CNVs in 197 addi-
tional multiplex IMGSAC autism families (320 affected individu-
als) and 461 Caucasian control subjects using six exonic QMPSF
probes. No additional DOCK4 deletions or duplications were
DOCK4 - exon26     IMMP2L - exon
A
594 kb
BLys Glu Glu Leu Arg Val Ser Stopeen in ASD families, besides the deletion in family 15-0084
escribed above and the duplication in family 13-3023 reported
reviously (23). No CNVs were seen in the control subjects.
Recent studies have shown that deletions that extend from
ne gene to the next can lead to potentially deleterious fusion
ranscripts (16). As IMMP2L and DOCK4 are transcribed in the
ame direction, we assessed whether the presence of the dele-
ion results in a fusion transcript. Indeed, RT-PCR and Sanger
equencing detected a fusion transcript that was not present in
ontrol RNA. The IMMP2L section of the DOCK4-IMMP2L fusion
ranscript is out of frame. Only two novel amino acids (Valine-
erine) would be translated, immediately followed by a prema-
ure stop codon (Figure 1B). It is thus likely to be subject to
onsense-mediated-decay, consistent with semiquantitative RT-
CR data suggesting that this fusion transcript was present at low
evels in relation to the wild-type transcript. Expression of the
ormal DOCK4 transcript was evaluated by qRT-PCR in the
other with the deletion and found to be 30% to 50% lower
ompared with the father with normal copy number.
Long-range PCR was used to screen the mother’s extended
amily for this 594 kb IMMP2L-DOCK4 deletion. The presence of
Figure 1. Molecular characterization of the IMMP2L-
DOCK4 deletion. (A) Shows sequence electropherogram
from the long-range PCR product spanning the deletion,
aligned with the BeadStudio plots of the log R ratio and B
allele frequency data from the 1M SNP array for 15-0084-
003. Red plot indicates 1 Mb moving-window average of
the log R ratio across the region chr7:109.5-112.5 Mb. (B)
Shows sequence from RT-PCR product showing evidence
of a transcript that fuses DOCK4 exon 26 onto IMMP2L
exon 4. PCR, polymerase chain reaction; RT-PCR, real-
time-polymerase chain reaction; SNP, single nucleotide
polymorphism.4www.sobp.org/journal
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324 BIOL PSYCHIATRY 2010;68:320–328 A.T. Pagnamenta et al.the deletion in the proband’s brother, sister, mother, uncle, and
two cousins, all of whom performed poorly on reading assess-
ment (Figure 2, Table S1 in Supplement 1), suggested that this
deletion may also act as a risk factor for dyslexia. These findings
led us to assess the NeuroDys cohort comprising 606 unrelated
individuals with dyslexia that were tested for CNVs using In-
finium SNP arrays. There was a deletion of DOCK4 exons 38 to
2 (detected on the 300K array, log Bayes Factor  44, validated
y QMPSF and quantitative PCR) in a single dyslexia case, but no
xonic deletions of DOCK4 were detected in 2091 control
samples tested on the 550 K SNP array (p  .225, Fisher’s exact
test). This 132 kb deletion was transmitted from a father reported
to have had dyslexia in childhood. Both the father and son
presented with slow reading speed. The unaffected sister had not
inherited the deletion.
To assess the genomic context of the IMMP2L-DOCK4 dele-
tion in family 15-0084, all 43 CNVs detected in the proband with
log Bayes Factor  10 were analyzed. While most other CNVs
ere well represented in the DGV, one on chromosome 2 was
otable (Figure 3A). This was the second highest ranking CNV,
etected with log Bayes Factor of 313 (Table 1 and Table S3 in
upplement 1). This 227 kb deletion removes exons 4 to 11 of
NTNAP5. There were no exonic deletions of this gene listed in
he DGV or in 2091 control samples tested on the 550K SNP
rray. Nested long-range PCR was used to validate this deletion
nd resolve the breakpoints to 6 kb LINE-1 elements. Segregation
nalysis indicated that this deletion had been transmitted from
he father to both autistic sons but not to their dyslexic sister
Figure 2, Table 1).
Interestingly, the father with the CNTNAP5 deletion was
eported to exhibit various autistic traits, although he declined
ormal testing. In addition, various neuropsychiatric traits were
escribed in members of his extended family, including eight
thers with reported impairments in social communication. We
ypothesized that these relatives may have inherited the same
eletion of CNTNAP5. However, DNA was only available for the
roband’s paternal aunt (who was reported to have schizophre-
ia) and she did not carry the CNTNAP5 deletion.
CNTNAP5 transcripts missing exons 4 to 11 are predicted to
esult in a frameshift, with 54 novel amino acids followed by
Figure 2. Inheritance pattern of the IMMP2L-DOCK4 deletion within the ex
deletion is present. Gel lanes are aligned with the pedigree, with proband in
in base pairs. Dark shading indicates ADI-defined autism, lighter shading
dyslexic diagnosis or reading impaired. Asterisk indicates presence of CNTNAP5
chain reaction.
www.sobp.org/journalremature termination codon but also probably inducing non-
ense-mediated-decay. However, CNTNAP5 was undetectable in
lood RNA by RT-PCR, so it was not possible to confirm the
unctional effect of this exonic deletion.
As there are no disruptions of CNTNAP5 reported in eight
ecent whole genome CNV scans listed in the Autism Chromo-
ome Rearrangement Database (http://projects.tcag.ca/autism,
ecember 2009 update), we decided to further assess the
otential role of rare CNTNAP5 variants in ASD, by sequencing
ll 24 exons and intron-exon boundaries for probands from 143
SD families. Three nonsynonymous mutations were detected in
aucasian ASD probands that were not present in dbSNP build
30 (36). The first was a c.2141C G transversion in exon 14 that
redicts a proline to arginine change at position 714 (P714R) of
he amino acid sequence (Figure 3B) in the fibrinogen C-terminal
omain. This mutation was maternally transmitted to both af-
ected sons but not to their unaffected sister (Figure S1A in
upplement 1). Although position 714 (P714R) is not conserved
hrough evolution (bioinformatics analysis predicted this change
o be benign), the loss of a proline residue may alter protein
tructure. Using PCR-restriction fragment length polymorphism
RFLP), this mutation was detected in only 1/932 Caucasian
ontrol chromosomes. The second mutation was a c.2756C  T
ransition in exon 18 that predicts a threonine to methionine
T919M) change (Figure 3C) in the laminin G-like 3 domain. This
utation, found in a German family, was maternally transmitted
o both affected children but not to their two unaffected siblings
Figure S1B in Supplement 1). Based on the alignment of
omologous protein sequences around position 919, bioinfor-
atic analysis predicted that this amino acid substitution is likely
o have a damaging effect. Using PCR-RFLP, this variant was not
etected in 1222 Caucasian control chromosomes, of which 660
ere German. The third mutation was a c.3502G  A transition
n exon 22 that predicts a valine to isoleucine (V1168I) change
Figure 3D) within the laminin G-like 4 domain. This mutation,
ound in another German family, was maternally transmitted to
oth affected sons but not to their unaffected brother (Figure S1C
n Supplement 1). Although this is a relatively minor amino acid
hange (both are aliphatic residues and hence bioinformatic
nalysis predicted this change to be benign), V1168I is highly
d family. Long-range PCR products of 3087 bp are visible only where this
ed by an arrow. The size of relevant bands in the DNA ladder are indicated
tes Asperger syndrome or autistic features, and diagonal stripes indicatetende
dicat
indicadeletion. ADI, Autism Diagnostic Interview; bp, base pair; PCR, polymerase
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A.T. Pagnamenta et al. BIOL PSYCHIATRY 2010;68:320–328 325conserved across species. The PCR-RFLP assay also did not
detect this change in 1232 control chromosomes, of which 692
were German.
The two changes that were not detected in control subjects
(T919M and V1168I) were further assessed by PCR-RFLP in a
cohort of 380 unrelated German ASD patients. While no addi-
tional cases of T919M were detected, the V1168I mutation was
seen in a second German ASD case. Therefore, in total, this
change was found in 2 of 523 ASD probands and 0 of 616 control
B
C
D
T G G G G A G G T T C C C T C C T G G G G 
Trp Gly Gly Ser         Pro   Gly V
c.2141C>G
CG
ProArg
c.2756C>T 
c.3502G>A
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Cys Met   Ser   Ser Gln Tyr As
GA
ValIlesubjects (p .211). However, in this second family, the mutation sad not been transmitted to an affected brother (Figure S1D in
upplement 1).
The exon 22 RFLP assay for V1168I was also able to detect a
.3584C T transition polymorphism that predicts a threonine to
ethionine (T1195M) change. In total, this polymorphism
rs34165507) was detected at a 3.1% minor allele frequency in
SD cases (32 of 1046 chromosomes) compared with 2.9% in
ontrol subjects (36 of 1232 chromosomes).
Finally, DNA from the ASD proband 15-0084-003 was also
C A G
 Gln
C A G
Gln
A C
His
Figure 3.Molecular analysis of CNTNAP5. (A) Shows the log
R ratio and B allele frequency 1M SNP data for 15-0084-003.
Red plot indicates 1Mbmoving-window average of the log
R ratio across the region chr2:124.5-125.5 Mb. (B–D) Shows
sequence electropherograms of the three novel nonsyn-
onymous variants detected in CNTNAP5. SNP, single nucle-
otide polymorphism.T C 
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nequenced to determine whether the paternally inherited CNTNAP5
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326 BIOL PSYCHIATRY 2010;68:320–328 A.T. Pagnamenta et al.deletion was potentially unmasking maternally inherited variants in
the same gene. However, only a novel T  C change in a
nonconserved region of the 5=-UTR and another common intronic
polymorphism (rs924802) were detected, neither of which are likely
to affect gene expression or function.
Discussion
In our earlier study, coincident SNP association and CNV data
in AUTS1 implicated the IMMP2L-DOCK4 gene region in ASD
susceptibility (23). In contrast, another study using 7q-linked
ASD families did not see association in this gene region (37). This
discrepancy may be because the two studies used different
markers. In addition, the negative study may have been under-
powered, as only 30 families were used and the markers density
was insufficient for CNV analysis to be performed.
In the study described here, characterization of the 594 kb
deletion described earlier (23) using a high-density genome-wide
microarray has led to the discovery of a second rare deletion
within the same affected individuals disrupting the CNTNAP5
gene. We hypothesize that both CNVs contribute to the array of
phenotypes seen in family 15-0084. This study thus demonstrates
the importance of performing a high-resolution assessment of
genomic background, even after the detection of a rare and likely
damaging CNV using a targeted approach.
The rare 594 kb deletion results in an IMMP2L-DOCK4 fusion
transcript. Future studies should determine whether this is a
common property of deletions. The deletion was also detected in
the affected boys’ sister, mother, and five members of their
extended family. Although only 15-0084-004 had been formally
diagnosed as being dyslexic, the finding that the reading abilities
of 6 of 9 individuals with the deletion were weak or very weak,
and two other individuals were in the low-average range (Table
S1 in Supplement 1) led us to further assess the potential role of
DOCK4 deletions in dyslexia. Another DOCK4 deletion was
detected in one case that showed co-segregation with dyslexia
within the nuclear family. Combining QMPSF and 550 K SNP
array data was consistent with the DGV, indicating IMMP2L
dosage to be variable in control subjects, while exonic deletions
of DOCK4 were undetectable in  2500 control subjects. In
ontrast to recent CNV studies on attention-deficit/hyperactivity
isorder (38), our data therefore suggest that haploinsufficiency
f IMMP2L might be benign, with deletions of DOCK4 more
ikely to be of etiological relevance. Although larger studies
ould be required to reach formal significance and confirm the
elevance of DOCK4 to reading ability, it is worth noting that 1)
ase-control analysis does not consider the segregation seen, and
) a previous study of 11 large Finnish dyslexia pedigrees
etected linkage at 7q32 (maximum nonparametric genome-
ide linkage score of 2.77) 17.4 Mb distal to DOCK4 (39).
DOCK4 functions as a guanine nucleotide exchange factor
GEF), which activates both Rap1 and Rac1 small guanosine
riphosphate (GTP)ases by exchanging bound guanosine
iphosphate for free GTP (40) and thus acts as a positive
egulator of dendritic growth in neuronal cell lines (24). Inter-
stingly, a previous study found five families with rare nonsyn-
nymous variants in another GEF (cAMP-GEFII), which co-
egregated with ASD (41). Further studies to elucidate the role of
OCK4 in human neuronal cell lines and more generally the role
f GEF regulators of small GTPases in autism and dyslexia are
ow warranted.
There are five members of the human contactin-associatedrotein family (CNTNAP1–5). These transmembrane proteins are F
www.sobp.org/journalredominantly expressed in the central nervous system and are
hought to be involved in cell recognition and adhesion. Of the
ive, CNTNAP5 is perhaps the least well-studied. However, null
utations of one of the three mouse orthologs (Caspr5-2) result
n perinatal lethality, while heterozygous animals show no
bvious phenotype (42). A nonsynonymous SNP in CNTNAP5
as recently identified in a genome-wide pharmacogenomic
tudy as potentially influencing the effect of the drug risperidone
n negative symptoms in schizophrenia (43). Only a single
uman case with deletion of CNTNAP5 has been described
reviously (44). This patient harbored a complex de novo
hromosomal rearrangement involving chromosomes 1, 2, and
5 and exhibited learning disability and language impairment but
id not meet the criteria for ASD. Fine-mapping studies using
luorescence in situ hybridization and array-based comparative
enomic hybridization indicated that the complex rearrangement
nvolved eight separate breakpoints. Although the authors sug-
est that the cryptic deletion of CNTNAP5 may underlie the
henotype seen in this patient, the complexity of the genomic
earrangement complicates interpretation.
Given the role of related neurexin genes in synapse function,
he absence of exonic deletions of CNTNAP5 from 2091 control
ubjects, and the deletion’s co-segregation with ASD in family
5-0084, we hypothesized that other rare variants in this gene
ay influence ASD susceptibility. To examine this possibility,
equencing was carried out in 143 multiplex families. The
o-segregation with ASD seen in three of the four families and
he scarcity of the three novel missense mutations in control
ubjects is consistent with rare variants of this gene playing a role
n ASD susceptibility. The CNTNAP5 analysis undertaken here
as only included multiplex ASD families. This type of family is
ess likely to harbor de novo ASD risk factors than are sporadic
SD cases (6). Further studies into the potential role of CNTNAP5
n ASD should use sporadic cases to complement the work
escribed here. Additional studies should also help determine
he effect of these mutations on synapse function.
In conclusion, our data suggest that exonic deletions of
OCK4may act as a risk factor for reading impairment while rare
ariants in CNTNAP5 may confer ASD susceptibility. Genomic
isruption of both genes may have an additive effect and in this
amily appears to result in a more severe ASD phenotype. These
ata add to the emerging theme that the same genomic variants,
n combination with distinct genetic backgrounds, may contrib-
te to different phenotypes.
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